| Title |
Disease Modifying Therapies for the Management of Children with Spinal Muscular Atrophy (5q SMA): An Update on the Emerging Evidence
|
|---|---|
| Published in |
Drug Design, Development and Therapy, June 2022
|
| DOI | 10.2147/dddt.s214174 |
| Pubmed ID | |
| Authors |
Helgi Thor Hjartarson, Kristofer Nathorst-Böös, Thomas Sejersen |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Ecuador | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 73 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 73 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 10 | 14% |
| Unspecified | 4 | 5% |
| Researcher | 4 | 5% |
| Student > Bachelor | 4 | 5% |
| Student > Ph. D. Student | 4 | 5% |
| Other | 9 | 12% |
| Unknown | 38 | 52% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 12 | 16% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 5% |
| Biochemistry, Genetics and Molecular Biology | 4 | 5% |
| Unspecified | 4 | 5% |
| Neuroscience | 4 | 5% |
| Other | 5 | 7% |
| Unknown | 40 | 55% |
Attention Score in Context
This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 August 2023.
All research outputs
#2,636,499
of 25,815,269 outputs
Outputs from Drug Design, Development and Therapy
#138
of 2,284 outputs
Outputs of similar age
#57,164
of 448,755 outputs
Outputs of similar age from Drug Design, Development and Therapy
#3
of 42 outputs
Altmetric has tracked 25,815,269 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,284 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,755 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.